Five-year outcomes of retinal vein occlusion treated with vascular endothelial growth factor inhibitors

PURPOSE: Report 5-year outcomes of patients receiving anti-vascular endothelial growth factor (VEGF) for the treatment of macular oedema secondary to retinal vein occlusion (RVO. METHODS: Retrospective review of eyes with RVO which initiated anti-VEGF treatment. Data including age, gender, visual ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Spooner, Kimberly, Fraser-Bell, Samantha, Hong, Thomas, Chang, Andrew A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440600/
https://www.ncbi.nlm.nih.gov/pubmed/30997407
http://dx.doi.org/10.1136/bmjophth-2018-000249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440600/
https://www.ncbi.nlm.nih.gov/pubmed/30997407
http://dx.doi.org/10.1136/bmjophth-2018-000249

Ejemplares similares